Axogen (AXGN) Liabilities and Shareholders Equity (2010 - 2026)

Axogen's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $289.5 million for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 47.57% year-over-year to $289.5 million in Q1 2026; TTM through Mar 2026 was $933.0 million, a 19.49% increase from a year earlier, with the FY2025 full-year figure at $221.7 million, up 8.82% from the prior year.
• Liabilities and Shareholders Equity rose to $289.5 million in Q1 2026 per AXGN's latest filing, from $221.7 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $289.5 million in Q1 2026 and bottomed at $186.5 million in Q1 2024.
• The 5-year median for Liabilities and Shareholders Equity is $196.1 million (2022), against an average of $203.4 million.
• Across the five-year window, Liabilities and Shareholders Equity fell 6.88% in 2022 and surged 47.57% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $195.4 million in 2022, then gained by 0.74% to $196.8 million in 2023, then grew by 3.51% to $203.7 million in 2024, then gained by 8.82% to $221.7 million in 2025, then soared by 30.58% to $289.5 million in 2026.
• Per Business Quant, the three latest AXGN Liabilities and Shareholders Equity figures stand at $289.5 million (Q1 2026), $221.7 million (Q4 2025), and $216.4 million (Q3 2025).